Shattuck Labs, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Shattuck Labs, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 53% in 3 years; of every extra $100 of sales, $15,269 became extra profit. Higher than almost all Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 94% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 2 of the last 3 years; profit grew in 3 of 3. Steadier than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-338.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 94% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 3/3Sales grew in 2 of the last 3 years; profit grew in 3 of 3.
Steadier than 85% of Healthcare companies in United States.
Growth Efficiency Ratio
$15,269Sales grew 53% in 3 years; of every extra $100 of sales, $15,269 became extra profit.
Higher than almost all Healthcare companies in United States.
Asset Productivity Ratio
+53% / -56%In 3 years sales changed by +53% while total assets changed by -56%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-47.6×Operating cash was negative last year, while some debt falls due within a year.
Lower than 72% of Healthcare companies in United States.
Cash Cushion Ratio
+13%Cash, after subtracting all debt, equals 13% of its market value (net cash).
Higher than 55% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Shattuck Labs, Inc. made a loss over the last year. Shattuck Labs, Inc. owes $0.04 for every $1 it owns. Shattuck Labs, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossShattuck Labs, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.66The share price is 2.66 times Shattuck Labs, Inc.'s book value per share, higher than 51% of Healthcare companies in United States.
Market cap
$562 MThe total market value of all of Shattuck Labs, Inc.'s shares at today's price (share price × number of shares), larger than 56% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$211 MWhat Shattuck Labs, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.10Net worth divided by the number of shares. The share price of $5.60 is 2.7 times this, which is the P/B above.
Return on equity (ROE)
-39.2%Shattuck Labs, Inc. lost 39.2% of its shareholders' money over the last year, higher than 55% of Healthcare companies in United States.
Owes vs Owns
0.04×Shattuck Labs, Inc. owes $0.04 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Dividend yield
NoneShattuck Labs, Inc. does not currently pay a dividend.
Revenue growth
-83%Revenue fell 83% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Profit growth
LossShattuck Labs, Inc. made a loss in each of the last two years.
Profit margin
-4880.9%Shattuck Labs, Inc. lost $4881 for every $100 of revenue.
Cash vs debt
Net cashShattuck Labs, Inc. held $76 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Shattuck Labs, Inc.: $562 M ÷ $211 M (30 Jun 2026) = 2.7.
What is Shattuck Labs, Inc.'s return on equity?
Shattuck Labs, Inc. lost 39.2% of its shareholders' money over the last year, higher than 55% of Healthcare companies in United States.
How much does Shattuck Labs, Inc. owe compared with what it owns?
Shattuck Labs, Inc. owes $0.04 for every $1 it owns (low), lower than 97% of Healthcare companies in United States.
Does Shattuck Labs, Inc. pay a dividend?
No. Shattuck Labs, Inc. does not currently pay a dividend.
Is Shattuck Labs, Inc.'s revenue growing?
Revenue fell 83% in the year to Dec 2025, and grew 15% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.